{"id":51143,"date":"2026-07-02T12:57:20","date_gmt":"2026-07-02T16:57:20","guid":{"rendered":"https:\/\/netsurit.com\/en-us\/?page_id=51143"},"modified":"2026-07-08T05:55:27","modified_gmt":"2026-07-08T09:55:27","slug":"innovate-compliance-platform-novo-nordisk","status":"publish","type":"page","link":"https:\/\/netsurit.com\/en-us\/innovate-compliance-platform-novo-nordisk\/","title":{"rendered":"Case Study : Novo Nordisk"},"content":{"rendered":"\t\t
PHARMACEUTICAL CASE STUDY<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
A Conversation with<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\tAbout<\/strong> The company discovers, develops and manufactures medicines focused on serious chronic diseases, particularly diabetes and obesity, as well as rare blood and endocrine disorders. With operations across more than 170 countries, Novo Nordisk requires strong governance structures that can support a large, complex and highly regulated global organization.<\/p> As its policy environment continued to grow, Novo Nordisk needed a more scalable way to manage ethics and compliance policies across regions, teams and formats.<\/p> Industry<\/strong> Company Size<\/strong> Headquarter<\/strong> Founded<\/strong> Services<\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t For a global organization operating in a highly regulated environment, policy governance must be clear, consistent and easy to manage.<\/p> Novo Nordisk\u2019s existing policy environment had become fragmented across tools, regions and formats. This made it difficult to enforce consistency, manage updates, maintain traceability and ensure that employees were always accessing the latest approved versions.<\/p> As policy libraries grew and changed more frequently, manual processes and decentralized storage increased the risk of outdated content being used. This created unnecessary governance gaps, additional administrative effort and potential audit exposure.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t Netsurit worked with Novo Nordisk to design and implement the Ethics & Compliance Policy Platform<\/strong>, known as ECPP.<\/p> The platform was created as a governed, digital-first environment for policy publishing, access and lifecycle management. The goal was to replace fragmented tools and manual processes with a single, structured platform that could improve control, traceability, usability and scale across the global organization.<\/p> The rollout was delivered in phases: Phase 1<\/strong> established the governance foundation while Phase 2<\/strong> is designed to expand ECPP into a richer compliance knowledge hub.<\/p> The solution included:<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
Novo Nordisk<\/a> is a global healthcare company founded in 1923 and headquartered near Copenhagen, Denmark.<\/p>
Global Healthcare and Pharmaceuticals
<\/span><\/span><\/p>
69,000+<\/p>
Near Copenhagen, Denmark<\/p>
1923<\/p>\n\t\t\t\t\t\t\t
Challenge<\/h5>
\n\t\t\t\t\t\t\t
Solution<\/h5>
\n\t\t\t\t\t\t\t
\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\tNovo Nordisk\u2019s Story<\/h3>